2,4-dichloro-6-[2-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine
Structure Info
- Chemspace ID
- CSSB21332060039 (In-Stock Building Blocks)
- IUPAC Name
- 2,4-dichloro-6-[2-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine
- Mol formula
- C11H12Cl2N6O
- Mol weight
- 315 Da
- Catalog Number(s)
- BBLS21332060039, BBV-2181322263, EN300-54999543, bbls21332060039
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.42
- Heavy atoms count
- 20
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.545
- Polar surface area (Å)
- 81
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 0
![Chemical structure of 2,4-dichloro-6-[2-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine (C11H12Cl2N6O) - CSSB21332060039](/st/structure/200/a1304de805537e71cf5d295a9e31d5b8/CC1%253DNN%253DC%2528O1%2529C1CCCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png "C11H12Cl2N6O")
- Zoom the structure
- CSSB21332060039
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 935.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 979.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 1,024.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,068.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,113.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,185.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,231.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,791.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2,4-dichloro-6-[(2R)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332130100](/st/structure/200/ce22dfc07fc26651b3f061293ec25790/CC1%253DNN%253DC%2528O1%2529%255BC%2540H%255D1CCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[(2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332130099](/st/structure/200/252393df0de9d4272d76da0080e3daf4/CC1%253DNN%253DC%2528O1%2529%255BC%2540%2540H%255D1CCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB02214498099](/st/structure/200/7e4e7b5181b2d945f131e1c93a28691a/CC1%253DNN%253DC%2528O1%2529C1CCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[2-(1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine - CSSB20891415161](/st/structure/200/2943d2107b44c178f88cbaaf0e7ced7e/ClC1%253DNC%2528%253DNC%2528Cl%2529%253DN1%2529N1CCCCC1C1%253DNN%253DCO1.png)
![Chemical structure of 2,4-dichloro-6-[2-(5-methyl-1,2,4-oxadiazol-3-yl)piperidin-1-yl]-1,3,5-triazine - CSSB02247860314](/st/structure/200/b638173a6e38d4b9ca412d0cecfd0307/CC1%253DNC%2528%253DNO1%2529C1CCCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[2-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-1,3,5-triazine - CSSB21332129394](/st/structure/200/9bd668a9afdde54d0785352974482206/CC1%253DNOC%2528%253DN1%2529C1CCCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
